Literature DB >> 19466653

G-CSF administration in a small-for-size liver model.

Yuan Ji1, Uta Dahmen, Nodir Madrahimov, Fotima Madrahimova, Wei Xing, Olaf Dirsch.   

Abstract

BACKGROUND: Extended liver resection is applied in the treatment of liver tumors and during living-related liver transplantation. This procedure can lead to transient, in some patients even lethal liver failure. Administration of G-CSF is associated with an increased survival after toxic liver damage. It is the aim of this study to test the effect of G-CSF administration in the rat 90% extended liver resection model. MATERIALS: Rats with and without G-CSF treatment were subjected to 90% partial hepatectomy using a mass ligation technique. Animals were sacrificed 6 hr, 24 hr, and 7 days after resection. Read-out parameters were liver damage in terms of liver enzymes and histomorphological alterations. Hepatic regeneration was determined by measuring liver weight recovery and calculating the BrdU proliferation index of hepatocytes. G-CSF-receptor expression was visualized in both groups by immunohistochemistry. Expression of lipopolysaccharide-binding-protein (LBP) mRNA was evaluated by quantitative PCR.
RESULTS: Survival rate was increased in the G-CSF-treatment group. Full liver weight recovery within one week was only achieved in the treatment group and was accompanied by reduced liver damage. G-CSF-receptor upregulation subsequent to administration of G-CSF may indicate a direct receptor mediated effect of G-CSF on the liver. Upregulation of LBP mRNA in the liver of G-CSF treated animals--reported to be associated with an increased host defense--could demonstrate a mode of action of G-CSF.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19466653     DOI: 10.1080/08941930802713027

Source DB:  PubMed          Journal:  J Invest Surg        ISSN: 0894-1939            Impact factor:   2.533


  5 in total

1.  Does granulocyte-colony stimulating factor administration induce damage or repair response in schistosomiasis?

Authors:  Lobna Y Ghanem; Uta Dahmen; Olaf Dirsch; Mona Mf Nosseir; Soheir S Mahmoud; Wafaa Af Mansour
Journal:  World J Hepatol       Date:  2010-12-27

2.  Stem cell-based therapies for liver diseases: state of the art and new perspectives.

Authors:  Anna Chiara Piscaglia; Mariachiara Campanale; Antonio Gasbarrini; Giovanni Gasbarrini
Journal:  Stem Cells Int       Date:  2010-09-01       Impact factor: 5.443

3.  Granulocyte colony stimulating factor induces lipopolysaccharide (LPS) sensitization via upregulation of LPS binding protein in rat.

Authors:  Haoshu Fang; Anding Liu; Jian Sun; Alexandra Kitz; Olaf Dirsch; Uta Dahmen
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

4.  Modulation of Innate Immunity by G-CSF and Inflammatory Response by LBPK95A Improves the Outcome of Sepsis in a Rat Model.

Authors:  Haoshu Fang; Chuanfeng Hua; Stefanie Weiss; Anding Liu; Wenhui Cheng; Ralf Claus; Jürgen Rödel; Olaf Dirsch; Uta Dahmen
Journal:  J Immunol Res       Date:  2018-11-07       Impact factor: 4.818

5.  Biochemical Changes in Blood of Patients with Duchenne Muscular Dystrophy Treated with Granulocyte-Colony Stimulating Factor.

Authors:  Dorota Sienkiewicz; Wojciech Kułak; Grażyna Paszko-Patej; Bożena Okurowska-Zawada; Jerzy Sienkiewicz; Piotr Kułak
Journal:  Biomed Res Int       Date:  2019-03-13       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.